Skip to content

Efficacy of cellulose powder in reduction allergic symptoms in children with allergic rhinitis

Efficacy of cellulose powder in reduction allergic symptoms in children with allergic rhinitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20150325001
Enrollment
100
Registered
2015-03-25
Start date
2015-03-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis Dust mite allergy Allergic rhinitis Cellulose powder Dust mite allergy Total nasal symptoms score Nasal provocation test Rhinomanometry PNIF

Interventions

Cellulose powder spray from natural origin&#44
delivered through a patented delivery system. It is a medical device indicated in the prevention of airborne allergies. ,Placebo is made from lactose powder. It&#39
s safe for using via intranasal route. It is made to resemble drugs
both packaging and labelling
Cellulose powder,Placebo (Lactose powder)

Sponsors

Clinical Research Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University
Lead Sponsor
Allergy and Immunology Unit&#44
Collaborator
Department of Pediatrics&#44
Collaborator
Ramathibodi
Collaborator

Eligibility

Sex/Gender
All
Age
8 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Age 8-18 years old 2. Have persistent rhinitis symptoms for a minimum of 1 year 3. Positive skin prick test (SPT) for house dust mite allergen (D.pteronyssinus) 4. Positive nasal challenge test for D.pteronyssinus

Exclusion criteria

Exclusion criteria: 1. Patients with asthma, upper respiratory tract infections or nasal deformities 2. Patients with multiple sensitization from SPT 3. Received and receiving allergen immunotherapy 4. Patients with severe persistent AR

Design outcomes

Primary

MeasureTime frame
clinical symptoms of AR before and after treatment with cellulose powder 1 month after treatment with cellulose powder/placebo TNSS, Severity of clinical symptoms during nasal challenge, PNIF, Anterior Rhinomanometry

Secondary

MeasureTime frame
inflammatory response before and after treatment with cellulose powder 1 month after treatment with cellulose powder/placebo Nasal scraping for cellular analysis before and after treatment

Countries

Thailand

Contacts

Public ContactNatchanun Klangkalya

Faculty of Medicine Ramathibodi Hospital, Mahidol University

judge.ja@gmail.com+662-201-1760

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026